Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Breast Neoplasms 12Brain Neoplasms 6Breast Neoplasms, Male 5Glioblastoma 4Gliosarcoma 3Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Salivary Gland Neoplasms 2Prostatic Neoplasms 2Oligodendroglioma 2Glioma 2Gallbladder Neoplasms 2Ependymoma 2Carcinoma, Hepatocellular 2Bile Duct Neoplasms 2Astrocytoma 2Tongue Neoplasms 1Thyroid Neoplasms 1Thymoma 1Spinal Cord Neoplasms 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Neoplasms 1Melanoma 1Medulloblastoma 1Insulin-Like Growth Factor I, Resistance To 1Familial ependymoma 1Esophageal Neoplasms 1Endometrial Neoplasms 1Central Nervous System Neoplasms 1

Interventions

Radiotherapy 30Temozolomide 16Carboplatin 16Chemotherapy, Adjuvant 15Cisplatin 13Vincristine 12Magnetic Resonance Spectroscopy 12Cyclophosphamide 11Etoposide 10Carmustine 10Methotrexate 8Specimen Handling 7Peripheral Blood Stem Cell Transplantation 7Filgrastim 7X-Rays 6Thiotepa 6Surgical Procedures, Operative 6Phantoms, Imaging 6O(6)-benzylguanine 6Lomustine 6Biopsy 6motexafin gadolinium 4Nuclear Medicine Department, Hospital 4Drug Therapy 4Tamoxifen 3Psychiatric Rehabilitation 3Procarbazine 3Neoadjuvant Therapy 3Mental Status and Dementia Tests 3Irinotecan 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Central Nervous System Neoplasms × Lapatinib × Clear all
NCT00099060 2014-01-27

Lapatinib in Treating Patients With Recurrent Glioblastoma Multiforme

National Cancer Institute (NCI)

Phase 1/2 Completed
24 enrolled
CNSSarcoma

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡